What's in Dr Salouti Eye Research Center's pipeline?

Dr Salouti Eye Research Center has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Dr Salouti Eye Research Center's portfolio?

Top competitors by shared drug class: Bausch Health Americas, Inc., GlaxoSmithKline, Aswan University Hospital, Bausch & Lomb Incorporated, Eli Lilly and Company.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/dr-salouti-eye-research-center.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Dr Salouti Eye Research Center — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dr Salouti Eye Research Center pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Loteprednol (Lotemax)	Loteprednol (Lotemax)	marketed	Corticosteroid	Glucocorticoid receptor	Ophthalmology
Fluorometholone(FML)	Fluorometholone(FML)	marketed	Topical corticosteroid	Glucocorticoid receptor	Ophthalmology

Therapeutic area mix

Ophthalmology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bausch Health Americas, Inc. · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
Aswan University Hospital · 2 shared drug classes
Bausch & Lomb Incorporated · 2 shared drug classes
Eli Lilly and Company · 2 shared drug classes
Federal University of São Paulo · 2 shared drug classes
AstraZeneca · 2 shared drug classes
LEO Pharma · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Dr Salouti Eye Research Center:

Cite this brief

Drug Landscape (2026). Dr Salouti Eye Research Center — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/dr-salouti-eye-research-center. Accessed 2026-05-17.